Monthly Update27 Mar 2026, 03:20 pm
Vista Pharmaceuticals Ltd Announces Closure of Trading Window Until 48 Hours After Q4 and Year-Ending Results in 2026
AI Summary
Vista Pharmaceuticals Ltd, with scrip code 524711, has announced the closure of its trading window for all designated employees, directors, and officers. The closure will be in effect from 1st April, 2026, and will reopen 48 hours after the declaration of audited financial results for the quarter and year ending 31.03.2026. The exact date of the board meeting for considering the said audited financial results will be intimated in due course.
Key Highlights
- Vista Pharmaceuticals Ltd announces closure of trading window from 1st April, 2026
- Trading window to reopen 48 hours after Q4 and year-ending results declaration in 2026
- Designated employees, directors, and officers are advised not to enter into any transaction involving dealing/trading in shares during the closure period
- Exact date of board meeting for considering audited financial results to be announced later
- Closure in accordance with the Company's minimum Standards Code of Conduct and SEBI regulations
Price Impact
More from VISTAPH